ICD-10 category · Morphology of neoplasms · M850-M854
M850 Ductal and lobular neoplasms
21 codes under M850 in the South African Master Industry Table 2021, 21 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| M8500/2 | Intraductal carcinoma, noninfiltrating, NOS, in situ | Valid · not as primary | — |
| M8500/3 | Infiltrating duct carcinoma, NOS, malignant, primary site (C50.-) | Valid · not as primary | — |
| M8500/6 | Infiltrating duct carcinoma, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8501/2 | Comedocarcinoma, noninfiltrating, in situ (D05.-) | Valid · not as primary | — |
| M8501/3 | Comedocarcinoma, NOS, malignant, primary site (C50.-) | Valid · not as primary | — |
| M8501/6 | Comedocarcinoma, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8502/3 | Juvenile carcinoma of breast, malignant, primary site (C50.-) | Valid · not as primary | — |
| M8502/6 | Secretory carcinoma of breast, malignant, metastatic site | Valid · not as primary | — |
| M8503/0 | Intraductal papilloma, benign | Valid · not as primary | — |
| M8503/2 | Noninfiltrating intraductal papillary adenocarcinoma, in situ (D05.-) | Valid · not as primary | — |
| M8503/3 | Intraductal papillary adenocarcinoma with invasion, malignant, primary site (C50.-) | Valid · not as primary | — |
| M8503/6 | Intraductal papillary adenocarcinoma with invasion, malignant, metastatic site | Valid · not as primary | — |
| M8504/0 | Intracystic papillary adenoma, benign | Valid · not as primary | — |
| M8504/2 | Noninfiltrating intracystic carcinoma, in situ | Valid · not as primary | — |
| M8504/3 | Intracystic carcinoma, NOS, malignant, primary site | Valid · not as primary | — |
| M8504/6 | Intracystic carcinoma, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8505/0 | Intraductal papillomatosis, NOS, benign | Valid · not as primary | — |
| M8506/0 | Adenoma of nipple (D24), benign | Valid · not as primary | — |
| M8507/2 | Intraductal micropapillary carcinoma, in situ | Valid · not as primary | — |
| M8508/3 | Cystic hypersecretory carcinoma, malignant, primary site (C50.-) | Valid · not as primary | — |
| M8508/6 | Cystic hypersecretory carcinoma, malignant, metastatic site | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.